November 16, 2015 10:34am

 

Financial results/ earnings is a ‘scorecard’ of sorts for public stem, cell and gene therapy regmed companies.

The current LPS (loss per share) standings reflect the universes’ investing status; then add in their cash position for a better snapshot! By analyzing these comparisons, investors can begin to gauge the financial health versus the scientific opportunity and whether or not it deserves their investment.


COMPANY SYMBOL Q3/15 LOSS Q3/15 LPS Q3/15 CASH
Aduro Biotech, Inc. ADRO +$600 K +$0.01 $448.4 M  
Applied Genetic Technologies AGTC -$9.1 M -$0.53 $199.3 M
Asterias Biotherapeutics AST -$3.5 M -$0.09 $12.6 M
Athersys, Inc. ATHX -$6.5 M -$0.08 $28.5 M
Avalanche Biotechnologies, Inc. AAVL -$14.1 M -$0.55 $268.9 M
AxoGen, Inc. AXGN -$3 M -$0.11 $29.9 M
Bellicum Pharmaceuticals, Inc. BLCM -$13.4 M -$0.51  $163.2 M
BioLife Solutions, Inc. BLFS -$1.1 M -$0.09 $5.3 M
BioTime, Inc. BTX  -$13.6 M    -$0.18 $29.4 M
bluebird bio BLUE -$42.9 M -$1.18 $901.9 M
Brainstorm Cell Therapeutics Inc. BCLI -$2.6 M -$0.14 $17.1 M
Capricor CAPR -$2.9 M -$0.18 $17.2 M
Cellectis CLLS -€$12.7 M  -€$0.36  €279.4 M 
Cesca Therapeutics, Inc KOOL -$3.4 M -$0..08 $6.6 M
Cytori Therapeutics, Inc. CYTX -$5.8 M -$0.04 $19 M
Fate Therapeutics, Inc. FATE -$6.8 M -$0.24 $72.9 M
Fibrocell Science, Inc. FCSC -$1.5 M -$0.07 $36.9 M
Harvard Apparatus RM HART -$2.3 M -$0.19 $8.2 M
Histogenics Corporation HSGX -$8.1 M -$0.61 $37.7 M
ImmunoCellular Therapeutics, Ltd. IMUC -$3.4 M  -$0.04 $24.4 M
Intrexon Corporation XON -$38.4 M  -$0.34 $532.6 M 
Juno Therapeutics, Inc. JUNO -$23.24 M -$0.26 $1.27 billion
Kite Pharma, Inc. KITE -$27.4 M -$0.63  $364 M
Mesoblast Limited MBLTY      
MiMedx Group, Inc MDXG +$6.6 M +$0,06 $41.1 M
Caladrius, Inc. (formerly Neostem)  CLBS -$11.4 M -$0.21 $29.4 M
Neuralstem, Inc.  CUR -$5.6 M  -$0.06 $18.1 M
Northwest Biotherapeutics, Inc. NWBO      
Ocata Therapeutics, Inc. OCAT -$3.8 M -$0.09 $3.2 M
Opexa Therapeutic, Inc. OPXA -$2.8 M -$0.42 $15.59 M
Organovo Holdings, Inc. ONVO -$11.3 M -$0.12 $76.9 M
Osiris Therapeutics, Inc. OSIR -$374 K  -$0.02 $43.2
Pluristem Therapeutics, Inc. PSTI -$5.87 M  -$0.07 $10.8 M
ReNeuron Group PLC RENE.L      
Regenxbio RGNX -$7.3 M -$1.52 $224.4 M
Sangamo Biosciences, Inc. SGMO -$9.02 M -$0.13 $219.7 M
Spark Therapeutics, Inc. ONCE -$16.9 M -$0.70 $212.2 M
StemCells, Inc. STEM -$9.64 M -$0.09 $21.1 M
Stemline Therapeutics, Inc. STML -$9.2 M -$0.53 $28.5 M
uniQure N.V. QURE -€28.7 M  -€1.08  € 214.5 M
Verastem, Inc. VSTM -$15.54 M -$0.42 $120.5 M
Vericel Corporation VCEL -$4.4 M -$0.26 $18.7 M
VistaGen Therapeutics, Inc. VSTA -$8.55 M N/A N/A